REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$62.27
0.00%
(0.00) 1H
9 Okt, 4:56:00 PTG GMT-3 · BRL
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk REGN34...
Buka
R$60.78
Tinggi
R$62.27
Rendah
R$60.78
Permodalan Pasaran
76.86B
Purata volum
910.00
Volum
32.00
tgi 52 mgu
R$73.13
rdh 52 mgu
R$49.47
Syer tertunggak
101.14J
Bilangan pekerja
15K
Buka
R$60.78
Tinggi
R$62.27
Rendah
R$60.78
Permodalan Pasaran
76.86B
Purata volum
910.00
Volum
32.00
tgi 52 mgu
R$73.13
rdh 52 mgu
R$49.47
Syer tertunggak
101.14J
Bilangan pekerja
15K
Cerita berita
Daripada sumber web dan rakan kongsi berita
AD HOC NEWS
·
1 jam lalu
Regeneron stock trades 0.24 percent above its EUR 664.95 Xetra close
AD HOC NEWS
·
16 jam lalu
Regeneron stock costs EUR 668.30 with USD 77.1 billion market cap
AD HOC NEWS
·
20 jam lalu
Morgan Stanley raises target for Regeneron stock to USD 779
AD HOC NEWS
·
1 hari lalu
Regeneron stock pre-market: EUR 659.95, plus 0.05 percent
Profil
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Perihal Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Pekerja15.3K
Diasaskan1988
Ibu pejabatTarrytown, New York, Amerika Syarikat
Sektor-
Laman webregeneron.com